Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

A biomarker and drug technology, applied in biological testing, biomaterial analysis, measuring devices, etc., can solve problems such as technical proximity

Active Publication Date: 2016-12-14
PELAGO BIOSCI
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, biochemical processes and drug actions within the tumor environment are difficult to access with current technologies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
  • Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay
  • Method for identifying a biomarker indicative of a reduced drug response using a thermal shift assay

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0173] Materials and Methods

[0174] Human cancer cell line A549 (ATCC number CCL-185) was cultured in RPMI-1640 medium (Sigma-Aldrich) until it was cultured in a culture room (containing 5% CO 2 ), the RPMI-1640 medium contained 0.3g / L L-glutamine and was supplemented with 10% fetal bovine serum (FBS, Gibco / Life Technologies, Carlsbad, CA, USA ), 100 units / mL penicillin and 100 units / mL streptomycin (Gibco / Life Technologies).

[0175] Cell lysates were prepared by harvesting the cells and suspending the cell pellet in phosphate-buffered saline (PBS) to a cell concentration of 100,000 cells / ml at N 2 Three cycles of freeze-thaw in (l), and lysed cells were cleared from cell debris by centrifugation. The clarified lysate was divided into three aliquots and supplemented with DNA oligonucleotides PG1 or PG2 dissolved in ultrapure water, and as a control an equal amount of water was added to the third aliquot.

[0176] After incubation for 30 minutes at room temperature, the t...

example 2

[0178] Materials and Methods

[0179] Cells were grown and lysed as described in Example 1. After clarification of the lysate, the supernatant was aliquoted and one was supplemented with 5 mM EDTA to a final concentration to chelate out metal ions. Control samples were supplemented with an equal volume of ultrapure water. After incubation for 10 minutes at room temperature, the lysates were aliquoted into 8 tubes of PCR strips and heated to increasing temperatures (68 to 78°C, using two degree increments) for a duration of three minutes. After heating, the samples were allowed to cool and the precipitated proteins were separated by centrifugation at 20000*g for 17 minutes. The remaining supernatants containing varying amounts of soluble protein were subjected to standard SDS-Page and Western blot analysis using a specific primary RNR R2 antibody (Santa Cruz Biotechnology SC-126) at a 1 :400 dilution in skim dietary milk. Using Graphpad Prism 6.0 software, the resulting prot...

example 3

[0181] Materials and Methods

[0182] Cells were grown and lysed as described in Example 1. After clarification of the lysate, the supernatant was divided into aliquots, one supplemented with a final concentration of 1 mM cyclic AMP dissolved in ultrapure water. Control samples were supplemented with an equal volume of ultrapure water. After incubation for 10 minutes at room temperature, the lysates were aliquoted into 8 tubes of PCR strips and heated to increasing temperatures (40 to 80° C., using four degree increments) for a duration of three minutes. After heating, the samples were allowed to cool and the precipitated proteins were separated by centrifugation at 20000*g for 17 minutes. The remaining supernatants containing varying amounts of soluble proteins were subjected to standard SDS-Page and Western blot analysis using specific first proteins against catalytic subunit α and regulatory subunit 1α at a 1:400 dilution in nonfat dietary milk Kinase A antibody (Santa C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention concerns a method for identifying and using a biomarker, or creating a proteome profile, indicative of a reduced response to a drug in a patient involving a thermal shift assay on a sample. The method comprises the steps of a) heating a sample from a patient b) separating soluble from insoluble protein, c) analysing either or both the soluble and insoluble protein fractions of step b) to determine the melting temperature.

Description

technical field [0001] The present invention relates to methods for studying the biochemical activation state of proteins, particularly by using thermal shift assays, and methods for identifying candidate biomarkers associated with reduced drug response. Background technique [0002] More particularly, the invention relates to a method for identifying biomarkers indicative of a decreased response to a drug comprising the steps of heating a sample from a patient treated with the drug and responding to the drug, and a sample from a patient treated with the drug but not responding to the drug. Samples from patients with reduced response to the drug, analyzing the products to determine the melting temperature of at least one protein in each sample, and identifying the protein in the protein from the drug responsive patient compared to samples from patients with reduced drug response At least one protein in the sample has a different melting temperature. In particular, at least ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68
CPCG01N33/6803G01N33/6842G01N33/6848G01N2800/52
Inventor 丹尼尔·马丁内斯·莫利纳帕尔·诺尔德伦
Owner PELAGO BIOSCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products